pharmacology cns depressant

Upload: queenie-puzon

Post on 04-Apr-2018

227 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/29/2019 pharmacology CNS depressant

    1/31

    Central Nervous System

    Depressants

  • 7/29/2019 pharmacology CNS depressant

    2/31

    CNS Depressants

    Sedatives

    Drugs that have an inhibitory effect on theCNS to the degree that they reduce:

    Nervousness

    Excitability

    Irritability

    without causing sleep

  • 7/29/2019 pharmacology CNS depressant

    3/31

    CNS Depressants

    Hypnotics

    Calm or soothe the CNS to the point that theycause sleep

  • 7/29/2019 pharmacology CNS depressant

    4/31

    CNS Depressants

    Sedative-Hypnoticsdose dependent:

    At low doses, calm or soothe the CNSwithout inducing sleep

    At high doses, calm or soothe the CNS

    to the point of causing sleep

  • 7/29/2019 pharmacology CNS depressant

    5/31

    Sedative-Hypnotics:

    Barbiturates

    First introduced in 1903, standard agentsfor insomnia and sedation

    Habit-forming

    Only a handful commonly used today duein part to the safety and efficacy of:BENZODIAZEPINES

  • 7/29/2019 pharmacology CNS depressant

    6/31

    Sedative-Hypnotics:

    Barbiturates

    Four categories:

    Ultrashort

    mephobexital, thiamylal, thiopentalShort

    pentobarbital, secobarbital

    Intermediate

    aprobarbital, butabarbital,amobarbital

    Long

    Phenobarbital,mephobarbital

  • 7/29/2019 pharmacology CNS depressant

    7/31

    Sedative-Hypnotics:

    Barbiturates

    Barbiturates have a very narrow therapeuticindex.

    Therapeutic IndexDosage range within which the drug is effectivebut above which is rapidly toxic.

  • 7/29/2019 pharmacology CNS depressant

    8/31

    Sedative-Hypnotics:

    Barbiturates

    Mechanism of Action

    Site of action:

    Brain stem (reticular formation)

    Cerebral cortex

    By inhibiting GABA, nerve impulses traveling inthe cerebral cortex are also inhibited.

  • 7/29/2019 pharmacology CNS depressant

    9/31

  • 7/29/2019 pharmacology CNS depressant

    10/31

    Barbiturates and benzodiazepines actsimilarly to produce depression of centralnervous system function and behavior.

    Both classes of drugs enhance the abilityof the inhibitory neurotransmitter,gamma aminobutyric acid (GABA), toactivate a type of receptors known as

    GABA-A receptors. These drugs increasethe effectiveness of GABA by altering thereceptor so that GABA can bind more

    easily, an effect known as allostericregulation. Activation of the GABA-Areceptor opens an ion channel, allowingnegatively charged chloride ions to enter

    the cell, producing an inhibition of

    http://www2.csusm.edu/DandB/GABA.htmlhttp://www2.csusm.edu/DandB/GABA.html
  • 7/29/2019 pharmacology CNS depressant

    11/31

    GABA is the main inhibitory neurotransmitter

    in the central nervous system (CNS)..

  • 7/29/2019 pharmacology CNS depressant

    12/31

    Sedative-Hypnotics:

    Barbiturates

    Drug Effects

    Low doses: Sedative effects

    High doses: Hypnotic effects(also lowers respiratory rate)

  • 7/29/2019 pharmacology CNS depressant

    13/31

    Sedative-Hypnotics:

    Barbiturates

    Therapeutic Uses

    Hypnotics

    Sedatives

    Anticonvulsants

    Surgical procedures

  • 7/29/2019 pharmacology CNS depressant

    14/31

    Sedative-Hypnotics:

    Barbiturates

    Side Effects

    Body System Effects

    CNS Drowsiness, lethargy, vertigomental depression, coma

    Respiratory Respiratory depression, apnea,

    bronchospasms, cough

  • 7/29/2019 pharmacology CNS depressant

    15/31

    Sedative-Hypnotics:

    Barbiturates

    Side Effects

    Body System Effects

    GI Nausea, vomiting, diarrhea

    Other Agranulocytosis,vasodilation, hypotension,

    Stevens-Johnson syndrome

  • 7/29/2019 pharmacology CNS depressant

    16/31

    Sedative-Hypnotics:

    Barbiturates

    Toxicology

    Overdose frequently leads to respiratorydepression, and subsequently,

    respiratory arrest.Can be therapeutic:

    Anesthesia induction

    Uncontrollable seizures: phenobarbitalcoma

  • 7/29/2019 pharmacology CNS depressant

    17/31

    Sedative-Hypnotics:

    Barbiturates

    Drug InteractionsAdditive effects:

    antihistamines, benzodiazepines,

    narcotics, tranquilizersInhibited metabolism:

    MAOIs will prolong effects ofbarbiturates

    Increased metabolism:

    Reduces anticoagulant response,leading to possible clot formation

  • 7/29/2019 pharmacology CNS depressant

    18/31

    CNS Depressants:

    Benzodiazepines

    Most frequently prescribed sedative-hypnotics

    Most commonly prescribed drug classes

    Favorable side effects

    Efficacy

    Safety

  • 7/29/2019 pharmacology CNS depressant

    19/31

    CNS Depressants:

    BenzodiazepinesClassified as either:Sedative-hypnotic or Anxiolytic

    (Medication that relieves anxiety)

  • 7/29/2019 pharmacology CNS depressant

    20/31

    CNS Depressants:

    Benzodiazepines

    Sedative-Hypnotic Type

    Long-Acting:

    flurazepam (Dalmane), quazepam

    (Doral)

    Intermediate:

    temazepam (Restoril),

    estazolam (Prosom),

    Short-Acting:

    triazolam (Halcion)

  • 7/29/2019 pharmacology CNS depressant

    21/31

    CNS Depressants:

    Benzodiazepines

    Anxiolytic Type

    alprazolam (Xanax)

    chloridiazepoxide (Librium)diazepam (Valium)

    lorazepam (Ativan)

    midazolam (Versed)

    zolpidem (Ambien) and zaleplon (Sonata)

    (nonbenzodiazepine hypnotic agents, share characteristics)

  • 7/29/2019 pharmacology CNS depressant

    22/31

    Miscellaneous sedative-hypnotic

    agents

    chloral hydrate

    dexmedetomidine

    diphenhydraminedoxylamine

    eszopiclone

    CNS D

  • 7/29/2019 pharmacology CNS depressant

    23/31

    CNS Depressants:

    Benzodiazepines

    Mechanism of Action

    Depress CNS activity

    Affect hypothalamic, thalamic, and limbic

    systems of the brain

    Benzodiazepine receptors

    CNS D

  • 7/29/2019 pharmacology CNS depressant

    24/31

    CNS Depressants:

    Benzodiazepines

    Drug Effects

    Calming effect on the CNS

    Useful in controlling agitation andanxiety

    CNS D t

  • 7/29/2019 pharmacology CNS depressant

    25/31

    CNS Depressants:

    Benzodiazepines

    Therapeutic UsesSedation

    Sleep induction

    Skeletal muscle relaxationAnxiety relief

    Treatment of alcohol withdrawal

    Agitation

    Depression

    Epilepsy

    Balanced anesthesia

    CNS D t

  • 7/29/2019 pharmacology CNS depressant

    26/31

    CNS Depressants:

    Benzodiazepines

    Side Effects

    Mild and infrequent

    Headache DrowsinessDizziness VertigoLethargy

    Paradoxical excitement(nervousness) Hangover

    effect

  • 7/29/2019 pharmacology CNS depressant

    27/31

    CNS Depressants:

    Nursing Implications

    Before beginning therapy, perform athorough history regarding allergies, useof other medications,health history, and

    medical history.Obtain baseline vital signs and I & O,including supine and erect BPs.

    Assess for potential disorders orconditions that may be contraindications,and for potential drug interactions.

  • 7/29/2019 pharmacology CNS depressant

    28/31

    CNS Depressants:

    Nursing Implications

    Give 15 to 30 minutes beforebedtime for maximum effectivenessin inducing sleep.

    Most benzodiazepines (exceptflurazepam) cause REM rebound anda tired feeling the next day; use with

    caution in the elderly.Patients should be instructed toavoid alcohol and other CNS

    depressants.

  • 7/29/2019 pharmacology CNS depressant

    29/31

    CNS Depressants:

    Nursing Implications

    Check with physician before takingany other medications, including OTCmedications.

    It may take 2 to 3 weeks to noticeimproved sleep when takingbarbiturates.

    Abruptly stopping these medications,especially barbiturates, may causerebound insomnia.

  • 7/29/2019 pharmacology CNS depressant

    30/31

    CNS Depressants:

    Nursing Implications

    Safety is important

    Keep side rails up

    Do not permit smoking

    Assist patient with ambulation(especially the elderly)

    Keep call light within reach

    Monitor for side effects

  • 7/29/2019 pharmacology CNS depressant

    31/31

    CNS Depressants:

    Nursing Implications

    Monitor for therapeutic effects

    Increased ability to sleep at night

    Fewer awakenings

    Shorter sleep induction time

    Few side effects, such as hangovereffects

    Improved sense of well-being becauseof improved sleep